Establishment of the reference interval for serum pro-gastrin-releasing peptide in healthy adults of Chinese Han ethnicity

被引:4
|
作者
Zhao, Bing [1 ]
Zhang, Miaomiao [1 ]
Lin, Feng [2 ]
Xie, Jing [1 ]
Liang, Yan [3 ]
Yang, Zaixing [1 ]
机构
[1] Wenzhou Med Univ, Taizhou First Peoples Hosp, Huangyan Hosp, Dept Lab Med, Wenzhou, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Taizhou First Peoples Hosp, Huangyan Hosp, Dept Gen Surg, Wenzhou, Zhejiang, Peoples R China
[3] Second Mil Med Univ, Changzheng Hosp, Dept Lab Diagnost, Shanghai, Peoples R China
来源
关键词
Pro-gastrin-releasing peptide; reference interval; electrochemiluminescence assay; Chinese; adult; CELL LUNG-CANCER; TUMOR-MARKER; BIOMARKER;
D O I
10.1177/1724600818783416
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objective: The aim of this study is to establish the reference interval for serum pro-gastrin-releasing peptide (proGRP) determined by electrochemiluminescence immunoassay (ECLIA) in healthy Chinese Han ethnic adults. Methods: After screening, 9932 healthy Chinese Han adults (age range 18-95 years) were enrolled in this study, including 6220 men and 3712 women. Serum proGRP levels were measured by ECLIA. The reference interval was defined by non-parametric 95th percentile interval. Results: Serum proGRP levels conformed to a non-Gussian distribution. The reference interval for healthy Chinese Han adults calculated by the non-parametric method was 0-73.90 ng/mL in this study. Since serum proGRP levels were significantly correlated with age (r=0.226, P<0.001), the participants were divided into six age groups: 18-39, 40-49, 50-59, 60-69, 70-79, and > 80 years. No significant difference for serum proGRP levels was found between the sexes at each of six age groups. The reference intervals were gradually increased with age (65.35 ng/mL, 68.65 ng/mL, 74.10 ng/mL, 77.65 ng/mL, 84.57 ng/mL, and 98.03 ng/mL in 18-39, 40-49, 50-59, 60-69, 70-79, and > 80 years, respectively). Conclusions: We established the reference interval for serum proGRP, which was determined by ECLIA in the healthy Chinese Han population. Furthermore, our study suggests that it is necessary to establish the age-specific reference intervals for serum proGRP.
引用
收藏
页码:487 / 491
页数:5
相关论文
共 50 条
  • [1] Reference intervals for plasma pro-gastrin releasing peptide (ProGRP) levels in healthy adults of Chinese Han ethnicity
    Zhang, Jie
    Zhao, Ying
    Chen, Yu
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2014, 29 (04): : E436 - E439
  • [2] Stability of Pro-Gastrin-Releasing Peptide in Serum versus Plasma
    Yoshimura, Toru
    Fujita, Kenju
    Kawakami, Satoshi
    Takeda, Katsumichi
    Chan, Sabrina
    Beligere, Gangamani
    Dowell, Barry
    TUMOR BIOLOGY, 2008, 29 (04) : 224 - 230
  • [3] Clinical Application of Pro-Gastrin-Releasing Peptide
    Fang, Lili
    Huang, Zhongqiang
    Lin, Yongzhi
    Fu, Jianguo
    Liang, Xianming
    Liu, Fan
    CLINICAL LABORATORY, 2018, 64 (7-8) : 1259 - 1268
  • [4] Increased serum concentrations of pro-gastrin-releasing peptide in patients with renal dysfunction
    Kamata, K
    Uchida, M
    Takeuchi, Y
    Takahashi, E
    Sato, N
    Miyake, Y
    Okubo, M
    Kodama, T
    Yamaguchi, K
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (07) : 1267 - 1270
  • [5] Serum pro-gastrin-releasing peptide (31-98) in prostatic diseases
    Yashi, M
    Ishikawa, S
    Tokue, A
    UROLOGY, 2003, 62 (01) : 198 - 199
  • [6] A New Method for Determining Pro-Gastrin-Releasing Peptide
    Ohrvik, A.
    Olsson, M.
    Dahlen, U.
    Nilsson, O.
    CLINICAL CHEMISTRY, 2009, 55 (06) : A113 - A113
  • [7] Automated Immunoassay for Pro-gastrin-releasing Peptide (ProGRP)
    Kobayashi, Eiji
    Kinukawa, Hideki
    Komori, Makoto
    Sakurai, Yousuke
    Iizuka, Masayuki
    Saegusa, Haruhisa
    Yoshimura, Toru
    Fujita, Kenju
    Dowell, Barry
    TUMOR BIOLOGY, 2008, 29 : 72 - 72
  • [8] Pro-gastrin-releasing peptide in patients with benign and malignant diseases
    Molina, R
    Auge, JM
    Alicarte, J
    Filella, X
    Viñolas, N
    Ballesta, AM
    TUMOR BIOLOGY, 2004, 25 (1-2) : 56 - 61
  • [9] Serum pro-gastrin-releasing peptide (31-98) in prostatic diseases - Reply
    Nagakawa, O
    UROLOGY, 2003, 62 (01) : 199 - 199
  • [10] Pro-Gastrin-Releasing Peptide as a Biomarker in Lung Neuroendocrine Neoplasm
    Rosiek, Violetta
    Kogut, Angelika
    Kos-Kudla, Beata
    CANCERS, 2023, 15 (13)